×
About 11,165 results

ALLMedicine™ Erectile Dysfunction Center

Research & Reviews  3,282 results

Alternatives to whole gland treatment for localized prostate cancer: a review of novel ...
https://doi.org/10.1097/MOU.0000000000000981
Current Opinion in Urology; Benjamin TGR, Williams TR et. al.

May 14th, 2022 - The mainstays of the management of clinically localized prostate cancer have historically rested upon active surveillance, radiation therapy, or radical prostatectomy. Although both radiation and surgical treatment of localized prostate cancer can...

Acute Management of Prolonged, Recalcitrant Priapism in a Pediatric Patient.
https://doi.org/10.1542/peds.2021-054941
Pediatrics Sherrer R, Otto M et. al.

May 12th, 2022 - Although rare in pediatrics, ischemic priapism carries significant risk of erectile dysfunction if not treated promptly. We report a case of idiopathic ischemic priapism in a male aged 14 years, refractory to traditional therapies, including aspir...

Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/kms/

May 12th, 2022 - Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating co...

Effect of Erchonia Laser on Erectile Dysfunction
https://clinicaltrials.gov/ct2/show/NCT05371951

May 12th, 2022 - The purpose of this pilot study is to determine the effectiveness of the Erchonia® HLS™, manufactured by Erchonia Corporation (the Company), in providing improvement in erectile dysfunction.

A new strategy for stem cells therapy for erectile dysfunction: Adipose-derived stem ce...
https://doi.org/10.4111/icu.20220016
Investigative and Clinical Urology; Cheng J, Zheng Z et. al.

May 10th, 2022 - Our previous studies showed that nanotechnology improves derived adipose-derived stem cells (ADSCs) therapy for erectile dysfunction (ED). In this study, the Neuregulin-1(NRG1) gene was transfected into ADSCs with superparamagnetic iron oxide nano...

see more →

Guidelines  13 results

Acute Ischemic Priapism: An AUA/SMSNA Guideline.
https://doi.org/10.1097/JU.0000000000002236
The Journal of Urology; Bivalacqua TJ, Allen BK et. al.

Sep 9th, 2021 - Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation and results in a prolonged and uncontrolled erection. Given its time-dependent and progressive nature, priapism is a situation that both u...

My Treatment Approach to Multiple System Atrophy.
https://doi.org/10.1016/j.mayocp.2020.10.005
Mayo Clinic Proceedings; Coon EA, Ahlskog JE

Mar 7th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term manage...

Erectile Dysfunction: AUA Guideline.
https://doi.org/10.1016/j.juro.2018.05.004
The Journal of Urology; Burnett AL, Nehra A et. al.

May 11th, 2018 - The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction. A systematic review of the literature using the Pubmed, Embase, and Cochrane databases (search dates 1/1/1965 to 7/29/17) was ...

British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunctio...
https://doi.org/10.1016/j.jsxm.2018.01.023
The Journal of Sexual Medicine; Hackett G, Kirby M et. al.

Mar 20th, 2018 - This is an update of the 2008 British Society for Sexual Medicine (BSSM) guidelines. To provide up-to-date guidance for U.K. (and international) health care professionals managing male sexual dysfunction. Source information was obtained from peer-...

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From ...
https://doi.org/10.1016/j.jsxm.2016.11.324
The Journal of Sexual Medicine; Salonia A, Adaikan G et. al.

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

see more →

Drugs  295 results see all →

Clinicaltrials.gov  207 results

Effect of Erchonia Laser on Erectile Dysfunction
https://clinicaltrials.gov/ct2/show/NCT05371951

May 12th, 2022 - The purpose of this pilot study is to determine the effectiveness of the Erchonia® HLS™, manufactured by Erchonia Corporation (the Company), in providing improvement in erectile dysfunction.

A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus
https://clinicaltrials.gov/ct2/show/NCT05347329

May 3rd, 2022 - Sexual health is fundamental to the physical and emotional health and wellbeing of individuals, couples and families, and to the social and economic development of communities and countries" says the World Health Organization. Erectile dysfunction...

Pelvic Fascia spARing Radical Prostatectomy TrIAL
https://clinicaltrials.gov/ct2/show/NCT05155501

Apr 28th, 2022 - Traditional radical prostatectomy is the most popular treatment for clinically significant prostate cancer, however significant risks including urinary incontinence, erectile dysfunction, penile shortening, penile curvature/ deformation (Peyronie'...

Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
https://clinicaltrials.gov/ct2/show/NCT04391114

Apr 27th, 2022 - Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate gland, places pressure on the urethra and causes urination difficulties and bladder problems. Lower Urinary Tract Symptoms (LUTS) secondary to BPH is a common condit...

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered
https://clinicaltrials.gov/ct2/show/NCT05332340

Apr 25th, 2022 - Prostate cancer remains one of the most prevalent cancer in men. For its treatment, recent technological advances demonstrate that the most effective treatment is the Radical Prostatectomy (RP) procedure. However, although curative for Prostate Ca...

see more →

News  643 results

Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers?
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/98449

Apr 28th, 2022 - A dozen countries and six U.S. states have now reported unexplained acute hepatitis cases in kids, about 10% of which have required transplants; one suspected death has been reported as well. (The Independent) Surgeries, disease activity, and depr...

Erectile Dysfunction Drugs Linked With Risk for Eye Problems
https://www.medscape.com/viewarticle/972431

Apr 20th, 2022 - Regular use of certain erectile dysfunction drugs — phosphodiesterase type 5 inhibitors (PDE5 inhibitors) — may be associated with an increased risk for several ocular adverse events, according to new research. In a cohort study of 213,033 men, th...

Real-World Data Suggest Coprescribing PDE5 Inhibitors and Nitrates May Be Safe
https://www.medscape.com/viewarticle/972491

Apr 20th, 2022 - As coprescribing drugs for erectile dysfunction and oral organic nitrates for ischemic heart disease (IHD) surged, cardiovascular adverse events did not significantly increase, a new study finds. The authors of the new research specifically examin...

Real-world data suggest coprescribing PDE5 inhibitors and nitrates may be safe
https://www.mdedge.com/internalmedicine/article/253888/mens-health/real-world-data-suggest-coprescribing-pde5-inhibitors
Will Pass

Apr 19th, 2022 - As coprescribing drugs for erectile dysfunction and oral organic nitrates for ischemic heart disease (IHD) surged, cardiovascular adverse events did not significantly increase, a new study finds. The authors of the new research specifically examin.

Sexual-Enhancement Drugs Raise Risk of Vision Impairment
https://www.medscape.com/viewarticle/972271

Apr 18th, 2022 - (Reuters Health) - Men who regularly used Viagra and other popular erectile dysfunction prescription drugs were more likely to suffer visual impairment, including retinal detachment and blindness, a large cohort study finds. The adjusted risks for...

see more →

Patient Education  26 results see all →